نتایج جستجو برای: il28b

تعداد نتایج: 709  

2016
Ming-Ying Lu Ching-I Huang Ming-Yen Hsieh Tusty-Juan Hsieh Edward Hsi Pei-Chien Tsai Yi-Shan Tsai Ching-Chih Lin Meng-Hsuan Hsieh Po-Cheng Liang Yi-Hung Lin Nai-Jen Hou Ming-Lun Yeh Chung-Feng Huang Zu-Yau Lin Shinn-Cherng Chen Jee-Fu Huang Wan-Long Chuang Chia-Yen Dai Ming-Lung Yu

Hepatitis C virus (HCV) can replicate in peripheral blood mononuclear cells (PBMCs), which can produce interferon to defend against virus infection. We hypothesized that dynamic gene expression in PBMCs might impact the treatment efficacy of peginterferon/ribavirin in HCV patients. PBMCs were collected at baseline, 1st week and 4th week of treatment from 27 chronic HCV-1 patients with 48-week p...

Journal: :Journal of hepatology 2015
Tarik Asselah

Among the 170 million HCV-infected subjects worldwide (around 34 million) HCV-G4 accounts for approximately 20% of those infected. This population accounts for most new infections, with limited access to therapy. While in the US HCV-G4 is responsible for 1–2% of HCV infection, in the Middle East and Sub-Saharan African regions it is the main cause of HCV infection, with Southern Europe also det...

2014
Alicja E Grzegorzewska Grzegorz Ostromecki Paulina Zielińska Adrianna Mostowska Paweł P Jagodziński

BACKGROUND T-cell cytokine gene polymorphisms and vitamin D pathway gene polymorphisms were evaluated as possibly associated with end-stage renal disease (ESRD) resulting from type 2 diabetes mellitus (DM) nephropathy. METHODS Studies were conducted among hemodialysis (HD) patients with ESRD due to type 2 DM nephropathy, chronic glomerulonephritis, chronic infective tubulointerstitial nephrit...

2014
Hideyuki Tamai Ryo Shimizu Naoki Shingaki Yoshiyuki Mori Shuya Maeshima Junya Nuta Yoshimasa Maeda Kosaku Moribata Yosuke Muraki Hisanobu Deguchi Izumi Inoue Takao Maekita Mikitaka Iguchi Jun Kato Masao Ichinose

The aim of the present study was to predict sustained virological response (SVR) to telaprevir with pegylated interferon (PEG-IFN) and ribavirin using viral response within 2 weeks after therapy initiation. Thirty-six patients with genotype 1 hepatitis C virus (HCV) and high viral load were treated by telaprevir-based triple therapy. SVR was achieved in 72% (26/36) of patients. Significant diff...

2016
King-Wah Chiu Toshiaki Nakano Kuang-Den Chen Chih-Che Lin Tsung-Hui Hu Shigeru Goto Chao-Long Chen

To investigate the effect of IL28B single nucleotide polymorphisms (SNPs) (rs8099917 and rs12979860) in the donors and recipients on the outcome of Hepatitis C virus-RNA clearance after living donor liver transplantation (LDLT). The rs8099917 and rs12979860 genotypes in 50 donor and recipients pairs were explored on the pre-operative day (POD) and post-operative day 30 (POD30). There was a sign...

Journal: :hepatitis monthly 0
marwa khairy endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt rabab fouad endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt mahassen mabrouk endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt wafaa el-akel endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt abu bakr awad bioinformatic and statistic department, faculty of computer sciences, cairo university, cairo, egypt rabab salama endemic medicine department and hepatology unit, faculty of medicine, cairo university, cairo, egypt; endemic medicine and hepatology department, kasr el-aini faculty of medicine, cairo university, cairo, egypt. tel: +20-25262555, fax: +20-25326439

conclusions: absence of the c allele was significantly associated with failure of response. the presence of c allele was associated with a favorable outcome. afp is a strong baseline predictor of hcv treatment response. a decision tree model is useful for predicting the probability of response to therapy. patients and methods: the study included 263 chronic hcv egyptian patients receiving peg-i...

Journal: :Antiviral therapy 2015
Mauricio Venegas Jaime Poniachik Francisco Fuster Carmen Hurtado Rodrigo A Villanueva Javier Brahm

BACKGROUND The relevance of HBV genotype diversity on interferon (IFN) therapy outcome in chronic hepatitis B patients has recently been highlighted. Data available for genotype F is poor. The aim of this work was to analyse the response of HBV genotype F to treatment with IFN. Additionally, response was analysed according to the role of single nucleotide polymorphisms (SNPs) near to the IL28B ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید